637 related articles for article (PubMed ID: 10853987)
1. Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.
Salmon-Céron D; Mazeron MC; Chaput S; Boukli N; Senechal B; Houhou N; Katlama C; Matheron S; Fillet AM; Gozlan J; Leport C; Jeantils V; Freymuth F; Costagliola D
AIDS; 2000 May; 14(8):1041-9. PubMed ID: 10853987
[TBL] [Abstract][Full Text] [Related]
2. [The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients].
Cartón JA; Maradona JA; de Oña M; Asensi V; Melón S; García-Alcalde ML; Rodríguez-Junquera M; Moreno-Torrico A; de Zárraga M
Med Clin (Barc); 1999 Sep; 113(6):205-9. PubMed ID: 10472608
[TBL] [Abstract][Full Text] [Related]
3. Influence of highly active antiretroviral therapy on the development of CMV disease in HIV positive patients at high risk for CMV disease.
Verbraak FD; Boom R; Wertheim-van Dillen PM; van den Horn GJ; Kijlstra A; de Smet MD
Br J Ophthalmol; 1999 Oct; 83(10):1186-9. PubMed ID: 10502584
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of cytomegalovirus (CMV) DNA by real-time PCR for occurrence of CMV disease in HIV-infected patients receiving highly active antiretroviral therapy.
Gourlain K; Salmon D; Gault E; Leport C; Katlama C; Matheron S; Costagliola D; Mazeron MC; Fillet AM; ;
J Med Virol; 2003 Mar; 69(3):401-7. PubMed ID: 12526052
[TBL] [Abstract][Full Text] [Related]
5. Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy.
Jouan M; Savès M; Tubiana R; Carcelain G; Cassoux N; Aubron-Olivier C; Fillet AM; Nciri M; Sénéchal B; Chêne G; Tural C; Lasry S; Autran B; Katlama C;
AIDS; 2001 Jan; 15(1):23-31. PubMed ID: 11192865
[TBL] [Abstract][Full Text] [Related]
6. The pp65 antigenaemia test as a predictor of cytomegalovirus-induced end-organ disease in patients with AIDS.
Francisci D; Tosti A; Baldelli F; Stagni G; Pauluzzi S
AIDS; 1997 Sep; 11(11):1341-5. PubMed ID: 9302443
[TBL] [Abstract][Full Text] [Related]
7. CMV pp65 antigen testing is of limited utility in the diagnosis of concomitant CMV disease in HIV-infected patients in the HAART era.
Skiest DJ; Crosby C
J Clin Virol; 2003 Oct; 28(2):203-13. PubMed ID: 12957190
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of pp65 antigenaemia test for cytomegalovirus after initiation of highly active antiretroviral therapy.
Miguelez M; Diez O
AIDS; 1998 Dec; 12(17):2353-4. PubMed ID: 9863881
[No Abstract] [Full Text] [Related]
9. Significance of cytomegalovirus (CMV)-pp65 antigenemia in the diagnosis of CMV disease in human immunodeficiency virus-infected patients.
Reynes J; Montes B; Atoui N; Segondy M
J Med Virol; 1996 Jul; 49(3):195-8. PubMed ID: 8818964
[TBL] [Abstract][Full Text] [Related]
10. Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy. Spanish CMV-AIDS Study Group.
Casado JL; Arrizabalaga J; Montes M; Martí-Belda P; Tural C; Pinilla J; Gutierrez C; Portu J; Schuurman R; Aguirrebengoa K
AIDS; 1999 Aug; 13(12):1497-502. PubMed ID: 10465073
[TBL] [Abstract][Full Text] [Related]
11. Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy.
Deayton J; Mocroft A; Wilson P; Emery VC; Johnson MA; Griffiths PD
AIDS; 1999 Jul; 13(10):1203-6. PubMed ID: 10416523
[TBL] [Abstract][Full Text] [Related]
12. CMV DNA levels and CMV gB subtypes in ART-naive HAART-treated patients: a 2-year follow-up study in The Netherlands.
Goossens VJ; Wolffs PF; van Loo IH; Bruggeman CA; Verbon A
AIDS; 2009 Jul; 23(11):1425-9. PubMed ID: 19531930
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies.
Wohl DA; Zeng D; Stewart P; Glomb N; Alcorn T; Jones S; Handy J; Fiscus S; Weinberg A; Gowda D; van der Horst C
J Acquir Immune Defic Syndr; 2005 Apr; 38(5):538-44. PubMed ID: 15793363
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus infection: the point in 2001.
Salmon-Ceron D
HIV Med; 2001 Oct; 2(4):255-9. PubMed ID: 11737406
[TBL] [Abstract][Full Text] [Related]
15. Concurrent CMV and EBV DNAemia is significantly correlated with a delay in the response to HAART in treatment-naive HIV type 1-positive patients.
Panagiotakis SH; Soufla G; Baritaki S; Sourvinos G; Passam A; Zagoreos I; Stavrianeas N; Spandidos DA
AIDS Res Hum Retroviruses; 2007 Jan; 23(1):10-8. PubMed ID: 17263627
[TBL] [Abstract][Full Text] [Related]
16. Detection of late pp67-mRNA by NASBA in peripheral blood for the diagnosis of human cytomegalovirus disease in AIDS patients.
Blank BS; Meenhorst PL; Pauw W; Mulder JW; van Dijk WC; Smits PH; Roeles F; Middeldorp JM; Lange JM
J Clin Virol; 2002 Jul; 25(1):29-38. PubMed ID: 12126719
[TBL] [Abstract][Full Text] [Related]
17. Human cytomegalovirus infection among patients living with AIDS in a tertiary level hospital in India.
Chakravarti A; Tewari S; Bhalla P
J Int Assoc Physicians AIDS Care (Chic); 2010; 9(2):94-7. PubMed ID: 20484735
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
[TBL] [Abstract][Full Text] [Related]
19. Effect of highly active antiretroviral therapy on cytomegalovirus antigenaemia in AIDS patients.
Borges LH; Villas Boas LS; Warren-Santoro SH; Estevam MP; Uip DE; Savalli C; Curi M; Pannuti CS
Int J STD AIDS; 2001 Apr; 12(4):234-8. PubMed ID: 11319974
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
